ConductScience.org, home

Paper745014

On the mode of action of L-deprenyl in the human central nervous system.

Riederer P and 5 others. J Neural Transm, 1978. Cited by 111 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. On the mode of action of L-deprenyl in the human central nervous system. Papers, record 745014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/745014

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
On the mode of action of L-deprenyl in the human central nervous system.
PubMed
Journal
J Neural Transm
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
4.48
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riederer PP
2Youdim MBM B
3Rausch WDW D
4Birkmayer WW
5Jellinger KK
6Seemann DD

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PlateletsMajor topic
BrainMajor topic
PhenethylaminesMajor topic
SelegilineMajor topic
Dose-Response Relationship, Drug
Humans
Mitochondria
Monoamine Oxidase
Substrate Specificity

Source PubMed

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,101,049Monoamine oxidase. Its inhibition.Mod Probl Pharmacopsychiatry1975https://conductscience.org/library/papers/1101049PubMed
28,682Multiple forms of monoamine oxidase: fact and artefact.Life Sci1976https://conductscience.org/library/papers/8682PubMed
3745,014On the mode of action of L-deprenyl in the human central nervous system.J Neural Transm1978https://conductscience.org/library/papers/745014PubMed
45,659,776Some observations upon a new inhibitor of monoamine oxidase in brain tissue.Biochem Pharmacol1968https://conductscience.org/library/papers/5659776PubMed
54,607,554Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.Adv Biochem Psychopharmacol1974https://conductscience.org/library/papers/4607554PubMed
65,415,111Multiple forms of human brain mitochondrial monoamine oxidase.Nature1970https://conductscience.org/library/papers/5415111PubMed
71,172,524The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.J Neural Transm1975https://conductscience.org/library/papers/1172524PubMed
813,971,142[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr1962https://conductscience.org/library/papers/13971142PubMed
971,602Deprenyl in Parkinson's disease.Lancet1977https://conductscience.org/library/papers/71602PubMed
10834,248Dopamine is a monoamine oxidase B substrate in man.Nature1977https://conductscience.org/library/papers/834248PubMed
1165,560Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study.Lancet1977https://conductscience.org/library/papers/65560PubMed
125,054,207Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species.Adv Biochem Psychopharmacol1972https://conductscience.org/library/papers/5054207PubMed
13329,649Are there MAO inhibitors specific for dopamine metabolism?Adv Biochem Psychopharmacol1977https://conductscience.org/library/papers/329649PubMed
14890,205
Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
Br J Pharmacol1977https://conductscience.org/library/papers/890205PubMed
15696,465Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies.Adv Biochem Psychopharmacol1978https://conductscience.org/library/papers/696465PubMed
1613,901,297The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.J Anat1962https://conductscience.org/library/papers/13901297PubMed
17745,019Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.J Neural Transm1978https://conductscience.org/library/papers/745019PubMed

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
36,964,457Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations.J Neural Transm (Vienna)2023https://conductscience.org/library/papers/36964457PubMed
35,107,654A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease.J Neural Transm (Vienna)2022https://conductscience.org/library/papers/35107654PubMed
34,437,505Pharmacological Modulation of Behaviour, Serotonin and Dopamine Levels in Daphnia magna Exposed to the Monoamine Oxidase Inhibitor Deprenyl.Toxics2021https://conductscience.org/library/papers/34437505PubMed
31,562,557Selegiline: a molecule with innovative potential.J Neural Transm (Vienna)2020https://conductscience.org/library/papers/31562557PubMed
30,108,930Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease.Medchemcomm2018https://conductscience.org/library/papers/30108930PubMed
29,417,334Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.J Neural Transm (Vienna)2018https://conductscience.org/library/papers/29417334PubMed
27,065,872Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.Front Pharmacol2016https://conductscience.org/library/papers/27065872PubMed
22,936,314Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.Drug Metab Dispos2012https://conductscience.org/library/papers/22936314PubMed
22,110,357MAO-inhibitors in Parkinson's Disease.Exp Neurobiol2011https://conductscience.org/library/papers/22110357PubMed
19,396,396Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.J Neural Transm (Vienna)2009https://conductscience.org/library/papers/19396396PubMed
12,873,156Neuroprotective strategies in Parkinson's disease : an update on progress.CNS Drugs2003https://conductscience.org/library/papers/12873156PubMed
9,704,592Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.Neurochem Res1998https://conductscience.org/library/papers/9704592PubMed
9,285,463Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.J Neurol Neurosurg Psychiatry1997https://conductscience.org/library/papers/9285463PubMed
8,713,690Monoamine oxidase inhibitors. An update on drug interactions.Drug Saf1996https://conductscience.org/library/papers/8713690PubMed
8,390,270Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8390270PubMed
7,834,966Pharmacokinetic optimisation of therapy with newer antidepressants.Clin Pharmacokinet1994https://conductscience.org/library/papers/7834966PubMed
7,284,698Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.Br J Pharmacol1981https://conductscience.org/library/papers/7284698PubMed
6,793,694Effects of L-deprenyl on human growth hormone secretion.J Neural Transm1981https://conductscience.org/library/papers/6793694PubMed
6,777,463Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/6777463PubMed
6,776,576The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in man.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6776576PubMed

See all 30 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/745014

GET https://conductscience.org/api/papers/v1/745014/cited_by?page=2